Aims-To investigate and characterise the appearance of non-transferrin
bound iron (NTBI) in the serum of patients after cytotoxic chemothera
py and to compare this with the onset and duration of neutropenia. Met
hod-Non-transferrin bound iron was measured by a bleomycin assay in pa
tients undergoing intensive chemotherapy for treatment of acute leukae
mia or lymphoma. Results-NTBI was detected after 26 of 27 courses of c
hemotherapy and lasted for a mean of 14.5 days. The presence of NTBI c
orrelated with the serum iron binding saturation, but not with serum f
erritin. Neutropenia occurred after all courses of chemotherapy and la
sted for a mean of 20.0 days. NTBI and neutropenia occurred concurrent
ly after 23 courses of chemotherapy, and had a mean joint duration of
9.5 days. Conclusions-NTBI is consistently present in the serum of pat
ients after cytotoxic chemotherapy, often at the same time as the pati
ent is neutropenic. This may be an additional risk factor for the deve
lopment of infective episodes after chemotherapy.